Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VWFP1-ANKRD62P1 readthrough transcript (ENSG00000273244)
- Target
- ENSG00000273244
- Molecular classification
- Pseudogene, Readthrough transcript, Non-coding RNA (potential or putative)
01
Overview
The VWFP1-ANKRD62P1 readthrough transcript is a product of naturally occurring readthrough transcription between two adjacent pseudogenes, VWFP1 (Von Willebrand factor pseudogene 1) and ANKRD62P1 (ankyrin repeat domain 62 pseudogene 1). Such readthroughs are annotated at the RNA level and generally do not encode functional proteins. They are classified as pseudogene transcripts and are mainly of interest for genomic annotation and studies of transcriptome complexity. There is no evidence that this locus produces a translated product, functions as a protein, or plays a direct role in cellular pathways, disease, or as a drug target[1][2][6][7]. Summary: This locus is not a therapeutic target; it should not be considered further for drug development or biomarker studies. Its primary relevance is limited to genome annotation research purposes.
- Other names
- VWFP1-ANKRD62P1
02
Mechanism of action
None
03
Biological functions
None established
04
Disease associations
None established
Beyond the preview
Go deeper on VWFP1-ANKRD62P1 readthrough transcript (ENSG00000273244).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VWFP1-ANKRD62P1 readthrough transcript (ENSG00000273244).